Betaherpesviruses in transplant recipients

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue TOPIC T3, 2000, Pages 29-34

  Griffiths, P D ^a   Clark, D A ^a   Emery, V C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM ULCER; GRAFT REJECTION; HEPATITIS; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 7; INFECTION RISK; LIVER DISEASE; LIVER TRANSPLANTATION; PNEUMONIA; RISK FACTOR; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BETAHERPESVIRINAE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 0034076395     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Grundy, J. E., Shanley, J. D. & Griffiths, P. D. (1987). Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet ii, 996-9.
2. Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., Myerson, D. & Gooley, T. (1997). Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90, 2097-102.
3. Rubin, R. H. (1989). The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. Journal of the American Medical Association 261, 3607-9.
4. Ljungman, P. & Plotkin, S. A. (1995). Workshop of CMV disease: definitions, clinical severity scores, and new syndromes. Scandinavian Journal of Infectious Diseases Supplementum 99, 87-9.
5. Cope, A. V., Sweny, P., Sabin, C., Rees L., Griffiths, P. D. & Emery, V. C. (1997). Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. Journal of Medical Virology 52, 200-5.
6. Hassan-Walker, A. F., Kidd, I. M., Sabin, C., Sweny, P., Griffiths, P. D. & Emery, V. C. (1999). Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). Journal of Medical Virology 56, 182-7.
7. Cope, A. V., Sabin, C., Burroughs, A., Rolles, K., Griffiths, P. D. & Emery, V. C. (1997). Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. Journal of Infectious Diseases 176, 1484-90.
8. Gor, D., Sabin, C., Prentice, H. G., Vyas, N., Man, S., Griffiths, P. D. et al. (1998). Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplantation 21, 597-605.
9. Grob, J. P., Grundy, J. E., Prentice, H. G., Griffiths, P. D., Hoffbrand, A. V., Hughes, M. D. et al. (1987). Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections. Lancet i, 774-6.
10. Emery, V. C., Cope, A. V., Bowen, E. F., Gor, D. & Griffiths, P. D. (1999). The dynamics of human cytomegalovirus replication in vivo. Journal of Experimental Medicine 190, 177-82.
11. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M. et al. (1986). Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234, 596-601.
12. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. et al. (1988). Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i, 1065-7.
13. Hall, C. B., Long, C. E., Schnabel, K. C., Caserta, M. T., McIntyre, K. M, Costanzo, M. A. et al. (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. New England Journal of Medicine 331, 432-8.
14. + T cells. Proceedings of the National Academy of Sciences, USA 87, 748-52.
15. Torigoe, S., Kumamoto, T., Koide, W., Taya, K. & Yamanishi, K. (1995). Clinical manifestations associated with human herpesvirus 7 infection. Archives of Disease in Childhood 72, 518-9.
16. Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J., Martin, M. E. et al. (1995). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209, 29-51.
17. Nicholas, J. (1996). Determination and analysis of the complete nucleotide sequence of human herpesvirus. Journal of Virology 70, 5975-89.
18. Riddell, S. R. & Greenberg, P. D. (1997). T cell therapy of human CMV and EBV infection in immunocompromised hosts. Reviews in Medical Virology 7, 181-92.
19. Herbein, G., Strasswimmer, J., Altieri, M., Woehl-Jaegle, M. L., Wolf, P. & Obert, G. (1996). Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clinical Infectious Diseases 22, 171-3.
20. Osman, H. K., Peiris, J. S., Taylor, C. E., Warwicker, P., Jarrett, R. F. & Madeley, C. R. (1996). "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? Journal of Medical Virology 48, 295-301.
21. Schmidt, C. A., Wilbron, F., Weiss, K., Brinkmann, V., Oettle, H., Lohmann, R. et al. (1996). A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation. Transplantation 61, 662-4.
22. Griffiths, P. D., Ait-Khaled, M., Bearcroft, C. P., Clark, D. A., Quaglia, A., Davie, S. E. et al. (1999). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. Journal of Medical Virology 59, 496-501.
23. Wilbom, F., Brinkmann, V., Schmidt, C. A., Neipel, F., Gelderblom, H. & Siegert, W. (1994). Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 83, 3052-8.
24. Appleton, A. L., Sviland, L., Peiris, J. S., Taylor, C. E., Wilkes, J., Green, M. A. et al. (1995). Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle-upon-Tyne Bone Marrow Transport Group. Bone Marrow Transplantation 16, 777-82.
25. Wang, F. Z., Dahl, H., Linde, A., Brytting, M., Ehrnst, A. & Ljungman, P. (1996). Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 96, 3615-20.
26. Kadakia, M. P., Rybka, W. B., Stewart, J. A., Patton, J. L., Stamey, F. R., Elsawy, M. et al. (1996). Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 87, 5341-54.
27. Chan, P. K., Peiris, J. S., Yuen, K. Y., Liang, R. H., Lau, Y. L., Chen, F. E. et al. (1997). Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. Journal of Medical Virology 53, 295-305.
28. Cone, R. W., Huang, M. L., Corey, L., Zeh, J., Ashley, R. & Bowden, R. (1999). Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. Journal of Infectious Diseases 179, 311-8.
29. Kidd, I. M., Clark, D. A., Ait-Khaled, M., Griffiths, P. D. & Emery, V. C. (1996). Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. Journal of Infectious Diseases 174, 396-401.
30. Clark, D. A., Ait-Khaled, M., Wheeler, A. C., Kidd, I. M., McLaughlin, J. E., Johnson, M. A. et al. (1996). Quantification of human herpesvirus 6 in immunocompetent persons and postmortem tissues from AIDS patients by PCR. Journal of General Virology 77, 2271-5.
31. Kidd, I. M., Clark, D. A., Bremner, J. A. G., Pillay, D., Griffiths, P. D. & Emery, V. C. (1998). A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. Journal of Virological Methods 70, 29-36.
32. Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J. P., Kovarik, J., Brennan, P. J. et al. (1999). Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. New England Journal of Medicine 340, 1462-70.
33. He, Z., He, Y. S., Kim, Y., Chu, L., Ohmstede, C., Biron, K. K. et al. (1997). The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. Journal of Virology 71, 405-11.
34. Ansari, A. & Emery, V. C. (1999). The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. Journal of Virology 73, 3284-91.
35. Yoshida, M., Yamada, M., Tsukazaki, T., Chatterjee, S., Lakeman, F. D., Nii, S. et al. (1998). Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Research 40, 73-84.